Machina Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Machina Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.31M	Buy	9,654 +4,590	+91%	+$2.14M	0.85%	17
2025 Q4	$2.3M	Sell	5,064 -6,103	-55%	-$2.63M	0.44%	76
2025 Q3	$4.37M	Buy	+11,167	New	+$4.67M	0.77%	30
2024 Q3	–	Sell	-2,117	Closed	-$992K	–	365
2024 Q2	$992K	Buy	2,117 +123	+6%	+$53.4K	0.45%	83
2024 Q1	$834K	Buy	+1,994	New	+$843K	0.44%	86
2023 Q4	–	Sell	-2,348	Closed	-$816K	–	361
2023 Q3	$816K	Buy	+2,348	New	+$821K	0.46%	83
2023 Q2	–	Sell	-900	Closed	-$284K	–	530
2023 Q1	$284K	Sell	900 -200	-18%	-$60K	0.25%	150
2022 Q4	$318K	Buy	+1,100	New	+$335K	0.59%	80
2020 Q1	–	Sell	-3,481	Closed	-$762K	–	294
2019 Q4	$762K	Sell	3,481 -1,251	-26%	-$253K	0.3%	133
2019 Q3	$802K	Sell	4,732 -743	-14%	-$131K	0.37%	98
2019 Q2	$1M	Sell	5,475 -9,172	-63%	-$1.6M	0.38%	90
2019 Q1	$2.69M	Buy	14,647 +13,780	+1,589%	+$2.55M	1.07%	9
2018 Q4	$144K	Buy	+867	New	+$150K	0.1%	225

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Machina Capital's VRTX Position: Q1 2026 in Review

Machina Capital increased its Vertex Pharmaceuticals (VRTX) stake by 91% in Q1 2026, buying an estimated $2.14M and bringing the position to 9,654 shares worth $4.31M. The position accounts for 0.85% of the portfolio, ranked #17.

Machina Capital first reported a position in VRTX in Q4 2018 and has held it in 13 quarters since. The position peaked at $4.37M in Q3 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Machina Capital held 9,654 shares of Vertex Pharmaceuticals worth $4.31M as of Q1 2026.
Machina Capital bought 4,590 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.14M.
Vertex Pharmaceuticals made up 0.85% of Machina Capital's portfolio in Q1 2026, its #17 holding.
Machina Capital first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 13 quarters since.
Machina Capital's Vertex Pharmaceuticals position peaked at $4.37M in Q3 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Machina Capital's 13F filing for Q1 2026, filed 13 May 2026.